Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients
Authors
Arjan A. van de Loosdrecht (ORCID: https://orcid.org/0000-0001-8311-983X)
Heleen Visser-Wisselaar
Annelies Verbrugge
Joop H. Jansen (ORCID: https://orcid.org/0000-0001-9459-568X)
Theresia M. Westers
Bert A. van der Reijden (ORCID: https://orcid.org/0000-0001-7804-8643)
Eline M.P. Cremers (ORCID: https://orcid.org/0000-0001-7388-8715)
Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients
Arjan A. van de Loosdrecht, Heleen Visser-Wisselaar, Annelies Verbrugge, Joop H. Jansen et al.
Journal
Haematologica
Topics
Protein Degradation and Inhibitors
article
Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients
Arjan A. van de Loosdrecht, Heleen Visser-Wisselaar, Annelies Verbrugge, Joop H. Jansen, Theresia M. Westers, Bert A. van der Reijden, Eline M.P. Cremers, Dana Chiţu, A. O. de Graaf, Canan Alhan, Carolien Duetz, Thessa N. Scheele, Florentien E.M. In’t Hout
article en
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(3)
Institutions
Radboud University Nijmegen (NL), Radboud University Medical Center (NL), Erasmus MC Cancer Institute (NL), Amsterdam University Medical Centers (NL), Vrije Universiteit Amsterdam (NL)